Is JAK2 V617F mutation more than a diagnostic index? A meta-analysis of clinical outcomes in essential thrombocythemia

被引：87
|
作者：
Dahabreh, Issa J. [1 ,2 ]
Zoi, Katerina [2 ]
Giannouli, Stavroula [1 ]
Zoi, Christine [1 ,2 ]
Loukopoulos, Dirnitrios [2 ]
Voulgarelis, Michael [1 ]
机构：
[1] Natl Tech Univ Athens, Sch Med, Dept Pathophysiol, Athens 11527, Greece
[2] Acad Athens, Biomed Res Fdn, Hemmatol Res Lab, Athens, Greece
来源：
LEUKEMIA RESEARCH | 2009年 / 33卷 / 01期
关键词：
Essential thrombocythemia; JAK2; V617F; Thrombosis; Systematic review; Meta-analysis; POLYCYTHEMIA-VERA; MYELOPROLIFERATIVE-DISORDERS; ALLELE BURDEN; RISK-FACTORS; 617V-GREATER-THAN-F MUTATION; JAK2(V617F) MUTATION; LEUKOCYTE ACTIVATION; JAK2-V617F MUTATION; THROMBOSIS; MYELOFIBROSIS;
D O I：
10.1016/j.leukres.2008.06.006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A systematic review and meta-analysis was carried out to compare the frequency of clinically significant outcomes between JAK2 V617F positive and wild type patients with essential thrombocythemia (ET). JAK2 V617F positivity in patients with ET was associated with a clear increase in the odds of thrombosis [OR = 1.83 (95% CI, 1.32-2.53), p < 0.0001], and much higher odds of transformation to polycythemia vera [OR = 7.67 (95% Cl, 2.04-28.87), p = 0.0009]. The mean difference of the white blood cell count between JAK2 positive and negative patients was associated with an increased odds ratio for thrombosis (p = 0.02). The JAK2 V617F mutation in patients with ET is associated with an increased risk of adverse cardiovascular outcomes via an increase in the leukocyte count. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码：67 / 73
页数：7
相关论文
共 50 条
  • [1] The JAK2 V617F mutation in essential thrombocythemia
    Cho, Young-Uk
    Chung, Hee-Jung
    Chi, Hyun-Sook
    Jang, Seoungsoo
    Park, Chan-Jeoung
    Lee, Jung-Hee
    Lee, Je-Hwan
    Lee, Kyoo-Hyung
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2007, 29 : 103 - 103
  • [2] Clinical implications of the JAK2 V617F mutation in essential thrombocythemia
    Antonioli, E
    Guglielmelli, P
    Pancrazzi, A
    Bogani, C
    Verrucci, M
    Ponziani, V
    Longo, G
    Bosi, A
    Vannucchi, AM
    LEUKEMIA, 2005, 19 (10) : 1847 - 1849
  • [3] Clinical implications of the JAK2 V617F mutation in essential thrombocythemia
    E Antonioli
    P Guglielmelli
    A Pancrazzi
    C Bogani
    M Verrucci
    V Ponziani
    G Longo
    A Bosi
    A M Vannucchi
    Leukemia, 2005, 19 : 1847 - 1849
  • [4] JAK2 V617F mutation in essential thrombocythemia.
    Ahn, Jeong Yeal
    Park, Pil Whan
    Seo, Yiel Hea
    Shin, Dong-Bok
    Lee, Jae-Hoon
    Yoo, Soo-Jin
    Bang, Soo-Mee
    BLOOD, 2006, 108 (11) : 318B - 318B
  • [5] Assessment of JAK2 V617F mutation in Tunisian patients with essential thrombocythemia
    Belhiba, M.
    Bellaaj, H.
    Keskes, L.
    Frikha, R.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1016 - 1016
  • [6] 2 DIFFERENT PHENOTYPES IN ESSENTIAL THROMBOCYTHEMIA: MUTATION JAK2 V617F OR CALR
    Vilches Moreno, A. S.
    Guerrero Fernandez, L.
    Latorre Gonzalez, A.
    Monteagudo Saiz, D.
    Robles Marina, V
    Andreu Costa, A.
    Ayala Diaz, R.
    Martinez Lopez, J.
    HAEMATOLOGICA, 2016, 101 : 187 - 187
  • [7] JAK2 V617F mutation to calreticulin mutation in an essential thrombocythemia patient: A case report
    Wang, Su-Yun
    Yang, Ning
    Zhang, Li-Jun
    Cheng, Zhi-Yong
    INDIAN JOURNAL OF CANCER, 2021, 58 (03) : 431 - 433
  • [8] ESSENTIAL THROMBOCYTHEMIA WITH JAK2 V617F OR CALR MUTATION: TWO DIFFERENT PHENOTYPES
    Vilches Moreno, A. S.
    Guerrero Fernandez, L.
    Gonzalez Medina, J.
    Ayala Diaz, R.
    Martinez Lopez, J.
    Monteagudo Saiz, D.
    Andreu Costa, M. A.
    Robles Marinas, V.
    HAEMATOLOGICA, 2016, 101 : 811 - 811
  • [9] IMPACT OF JAK2 V617F MUTATION ON CLINICAL OUTCOME OF PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA: A RETROSPECTIVE STUDY
    Wojcik, M.
    Renc, M.
    Skotnicki, A. B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 507 - 507
  • [10] Frequency and Clinical Features of the JAK2 V617F Mutation in Pediatric Patients With Sporadic Essential Thrombocythemia
    Nakatani, Takuya
    Imamura, Toshihiko
    Ishida, Hiroyuki
    Wakaizumi, Katsuji
    Yamamoto, Tohru
    Otabe, Osamu
    Ishigami, Tsuyoshi
    Adachi, Souichi
    Morimoto, Akira
    PEDIATRIC BLOOD & CANCER, 2008, 51 (06) : 802 - 805
12345